Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial
卡培他滨联合多西他赛、环磷酰胺和表柔比星辅助治疗三阴性乳腺癌(CBCSG010):一项开放标签、随机、多中心、III期试验
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.19.02474
Li, Junjie; Yu, Keda; Pang, Da; Wang, Changqin; Jiang, Jun; Yang, Suisheng; Liu, Yunjiang; Fu, Peifen; Sheng, Yuan; Zhang, Guojun; Cao, Yali; He, Qi; Cui, Shude; Wang, Xijing; Ren, Guosheng; Li, Xinzheng; Yu, Shiyou; Liu, Pengxi; Qu, Xiang; Tang, Jinhai; Wang, Ouchen; Fan, Zhimin; Jiang, Guoqin; Zhang, Jin; Wang, Jiandong; Zhang, Hongwei; Wang, Shui; Zhang, Jianguo; Jin, Feng; Rao, Nanyan; Ma, Binlin; He, Pingqing; Xu, Binghe; Zhuang, Zhigang; Wang, Jianfeng; Sun, Qiang; Guo, Xiaofeng; Mo, Miao; Shao, Zhimin